Interventional

Feature Article

Noncardiac Surgery Risk Stratification: Best Practices

Noncardiac Surgery Risk Stratification: Best Practices

Coronary angiography and revascularization use prior to noncardiac surgery continues to be debated.

Latest Features

FDA Issues Guidance on Medical Product Marketing Language

FDA Issues Guidance on Medical Product Marketing Language

The FDA has released draft guidance documents for appropriate marketing communication on medical products and devices.

Rheumatic Heart Disease: Diagnosis and Management

Rheumatic Heart Disease: Diagnosis and Management

Learn about the comprehensive management of rheumatic heart disease with Jack Boyd, MD, clinical assistant professor of cardiothoracic surgery at Stanford University School of Medicine.

Choosing Between PCI and Surgery for Left Main Coronary Artery Disease

Choosing Between PCI and Surgery for Left Main Coronary Artery Disease

While mortality rates were similar between percutaneous coronary intervention and coronary artery bypass grafting in both EXCEL and NOBLE trials, the risk of major cardiovascular events was higher in PCI in NOBLE.

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Bioresorbable Stents Promising But Metal Stents Still Have Role in Coronary Intervention

Experts say bioresorbable stents are "a few generations away" from being standard of care in interventional cardiology.

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

Deferred Stenting or Ischemic Postconditioning in STEMI Patients Did Not Reduce Adverse Events

A composite end point of death, heart failure, new myocardial infarction, and revascularization was similar between the deferred stenting group and the conventional treatment group.

Interventional Cardiology: A Look Back at 4 Decades of Practice-Changing Innovation

Interventional Cardiology: A Look Back at 4 Decades of Practice-Changing Innovation

An overview of the groundbreaking technology that has shaped interventional cardiology.

Transcatheter Aortic Valve Replacement: Current and Emerging Approaches

Transcatheter Aortic Valve Replacement: Current and Emerging Approaches

Transcatheter aortic valve replacement continues to evolve as a treatment for patients with symptomatic severe aortic stenosis, as well as for younger, lower-risk patients.

Latest News

Endovascular Treatment for Acute Ischemic Stroke Shows Benefits at 2 Years

Endovascular Treatment for Acute Ischemic Stroke Shows Benefits at 2 Years

The response to endovascular treatment for acute ischemic stroke after 2 years was as good as in the first 90 days.

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Patients with HbA1c levels had lower 7-year incidence of major adverse cardiac and cerebrovascular events compared with patients with higher HbA1c levels.

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

The effect of hypoglycemia on functional outcomes after endovascular thrombectomy differs, depending on collateral status.

Instantaneous Wave-Free Ratio Noninferior to Fractional Flow Reserve for Guiding PCI

Instantaneous Wave-Free Ratio Noninferior to Fractional Flow Reserve for Guiding PCI

Both iFR and FFR groups experienced similar rates of composite nonfatal myocardial infarction, unplanned revascularization, or all-cause death within 1 year post-procedure.

ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease

ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease

Revised coronary revascularization criteria rated whether coronary interventions are appropriate in tables organized according to practice patterns.

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

Target Lesion Failure and Stent Thrombosis Rates Low With SYNERGY

Target lesion failure was 5.8% at 1 year after implantation with the SYNERGY stent.

Everolimus-Eluting vs Sirolimus-Eluting Stents in Coronary Artery Disease

Everolimus-Eluting vs Sirolimus-Eluting Stents in Coronary Artery Disease

After 5 years, the cumulative incidence of MACE was 6.7% in the everolimus-eluting stent group and 11.2% in the sirolimus-eluting stent group.

TAVR Demonstrates Noniferiority to Surgery in Intermediate-Risk Patients

TAVR Demonstrates Noniferiority to Surgery in Intermediate-Risk Patients

At 2 years, the estimated incidence of the primary end point was 12.6% in the TAVR group vs 14% in the surgery group.

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location

Survival rates were high for patients with both central and peripheral pulmonary emboli.

Stroke Door-to-Needle Times Delayed, Affecting Outcomes

Stroke Door-to-Needle Times Delayed, Affecting Outcomes

Stroke treatment delays were attributed to inability of the care team to determine patient eligibility, hypertension needing aggressive treatment, and in-hospital delays.

Sign Up for Free e-Newsletters